Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(40%)

Phase Distribution

Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Terminated(3)
Other(2)

Detailed Status

Terminated2
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

terminated240%
unknown240%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
terminatednot_applicable

Endurant Evo International Clinical Trial

NCT02461524
terminatednot_applicable

Endurant Evo US Clinical Trial

NCT02393716
unknown

Aorfix Intelliflex First in Human Study

NCT02907762
unknownnot_applicable

Impact of Supra-renal Fixation of EVAR on Hemodynamics of Renal Arteries

NCT03594786
withdrawnnot_applicable

Post Implant Syndrome After EVAR and EVAS (INSPIRE Study)

NCT03763812

Clinical Trials (5)

Showing 5 of 5 trials
NCT02461524Not Applicable

Endurant Evo International Clinical Trial

Terminated
NCT02393716Not Applicable

Endurant Evo US Clinical Trial

Terminated
NCT02907762

Aorfix Intelliflex First in Human Study

Unknown
NCT03594786Not Applicable

Impact of Supra-renal Fixation of EVAR on Hemodynamics of Renal Arteries

Unknown
NCT03763812Not Applicable

Post Implant Syndrome After EVAR and EVAS (INSPIRE Study)

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5